Teva Pharmaceutical (TEVA)
NYSE:TEVA
Holding TEVA?
Track your performance easily

Teva Pharmaceutical (TEVA) Financial Statements

6,680 Followers

Teva Pharmaceutical Financial Overview

Teva Pharmaceutical's market cap is currently ―. The company's EPS TTM is $-0.394; its P/E ratio is -44.39; Teva Pharmaceutical is scheduled to report earnings on November 7, 2024, and the estimated EPS forecast is $0.66. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 4.16B$ 3.82B$ 4.46B$ 3.85B$ 3.88B
Gross Profit$ 2.02B$ 1.77B$ 2.42B$ 1.85B$ 1.80B
EBIT$ 179.00M$ 388.00M$ 694.00M$ 75.00M$ -914.00M
EBITDA$ 438.00M$ 660.00M$ 960.00M$ 358.00M$ -614.00M
Net Income Common Stockholders$ -422.00M$ -139.00M$ 429.00M$ 894.00M$ -863.00M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 2.26B$ 2.99B$ 3.23B$ 2.25B$ 2.67B
Total Assets$ 41.34B$ 42.77B$ 43.48B$ 42.09B$ 43.09B
Total Debt$ 18.92B$ 19.94B$ 20.15B$ 20.30B$ 21.02B
Net Debt$ 16.66B$ 16.95B$ 16.93B$ 18.05B$ 18.35B
Total Liabilities$ 31.08B$ 35.23B$ 35.35B$ 34.58B$ 31.95B
Stockholders Equity$ 10.06B$ 7.28B$ 7.51B$ 6.93B$ 10.48B
Cash Flow-
Free Cash Flow$ 6.00M$ -248.00M$ 1.06B$ -144.00M$ 205.00M
Operating Cash Flow$ 103.00M$ -124.00M$ 1.18B$ 5.00M$ 324.00M
Investing Cash Flow$ 178.00M$ 144.00M$ 301.00M$ 184.00M$ 302.00M
Financing Cash Flow$ -966.00M$ -151.00M$ -576.00M$ -576.00M$ -55.00M
Currency in USD

Teva Pharmaceutical Earnings and Revenue History

Teva Pharmaceutical Debt to Assets

Teva Pharmaceutical Cash Flow

Teva Pharmaceutical Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis